Výsledky vyhledávání

Akademický článek

Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm: INSTANT Phase 2 Trial.

Autor: Ruskin JN; Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: jruskin@mgh.harvard.edu., Camm AJ; St. George's University, London, United Kingdom., Dufton C; InCarda Therapeutics, Newark, California, USA., Woite-Silva AC; InCarda Therapeutics, Newark, California, USA., Tuininga Y; Deventer Hospital, Deventer, the Netherlands., Badings E; Deventer Hospital, Deventer, the Netherlands., De Jong JSSG; Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, the Netherlands., Oosterhof T; Ziekenhuis Gelderse Vallei, Ede, the Netherlands., Aksoy I; Admiraal de Ruyter Ziekenhuis, Goes, the Netherlands., Kuijper AFM; Spaarne Gasthuis, Haarlem, the Netherlands., Van Gelder IC; University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van Dijk V; St Antonius Ziekenhuis, Nieuwegein, the Netherlands., Nuyens D; Hartcentrum Ziekenhuis Oost-Limburg, Genk, Belgium., Schellings D; Slingeland Ziekenhuis, Doetinchem, the Netherlands., Lee MY; Long Beach Medical Center, Long Beach, California, USA., Kowey PR; Lankenau Heart Institute, Wynnewood, Pennsylvania, USA., Crijns HJGM; Maastricht University Medical Center (MUMC), Maastricht, the Netherlands., Maupas J; InCarda Therapeutics, Newark, California, USA., Belardinelli L; InCarda Therapeutics, Newark, California, USA.

Publikováno v: JACC. Clinical electrophysiology [JACC Clin Electrophysiol] 2024 Jun; Vol. 10 (6), pp. 1021-1033. Date of Electronic Publication: 2024 Apr 10.

Zobrazit plný text záznamu

Akademický článek

Percutaneous left atrial appendage occlusion in patients with a cardiac implantable electronic device.

Autor: Staal, D. P., Maarse, M., Aarnink, E., Huijboom, M. F. M., Abeln, B. G. S., Rensing, B. J. M. W., Swaans, M. J., Van Dijk, V. F., Boersma, L. V. A.

Publikováno v: Journal of Interventional Cardiac Electrophysiology; Dec2023, Vol. 66 Issue 9, p1971-1978, 8p

Zobrazit plný text záznamu

Report

The substernal implantable cardioverter-defibrillator: First experience combining an extravascular-implantable cardioverter-defibrillator with a dual-chamber transvenous pacemaker.

Autor: Römers H; Department of Cardiology, Sint Antonius Hospital, Nieuwegein, The Netherlands.; Department of Cardiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Liebregts M; Department of Cardiology, Sint Antonius Hospital, Nieuwegein, The Netherlands., van Dijk V; Department of Cardiology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Boersma L; Department of Cardiology, Sint Antonius Hospital, Nieuwegein, The Netherlands.; Department of Cardiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.

Publikováno v: HeartRhythm case reports [HeartRhythm Case Rep] 2023 Nov 23; Vol. 10 (2), pp. 132-136. Date of Electronic Publication: 2023 Nov 23 (Print Publication: 2024).

Zobrazit plný text záznamu

Akademický článek

Parfums Christian Dior SA v. Tuk Consultancy BV/Assco Gerüste GmbH and R. van Dijk v. Wilhelm Layher GmbH & Co KG and Layher BV.

Autor: Heliskoski, Joni

Publikováno v: Common Market Law Review; Feb2002, Vol. 39 Issue 1, p159-174, 16p

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chloroquine-induced QTc prolongation in COVID-19 patients

Autor: van den Broek, M. P.H., Möhlmann, J. E., Abeln, B. G.S., Liebregts, M., van Dijk, V. F., van de Garde, E. M.W., Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology

Publikováno v: Netherlands Heart Journal, 28(7-8), 406. Bohn Stafleu van Loghum
Netherlands Heart Journal
Netherlands heart journal, 28(7-8), 406-409. Bohn Stafleu van Loghum

Background In the battle against the SARS-CoV‑2 pandemic, chloroquine has emerged as a new potential therapeutic option for the treatment of infected patients. A safety consideration for the application of chloroquine is its QTc-prolonging potentia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ba21bac6f8a9efa6c796bbf7d80d6b6
https://doi.org/10.1007/s12471-020-01429-7

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání